about
Immune development and intestinal microbiota in celiac diseaseInfluence of early environmental factors on lymphocyte subsets and gut microbiota in infants at risk of celiac disease; the PROFICEL study.Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in childrenRole of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free ratsInfluence of breastfeeding versus formula feeding on lymphocyte subsets in infants at risk of coeliac disease: the PROFICEL study.The microbiota-gut-brain axis in functional gastrointestinal disorders.FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial.Human milk composition differs in healthy mothers and mothers with celiac disease.The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both?NSAID enteropathy and bacteria: a complicated relationship.Microbiota and host determinants of behavioural phenotype in maternally separated mice.SHP-2 Phosphatase Prevents Colonic Inflammation by Controlling Secretory Cell Differentiation and Maintaining Host-Microbiota Homeostasis.Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients.Impaired responses to gliadin and gut microbes of immune cells from mice with altered stress-related behavior and premature immune senescence.Influence of environmental and genetic factors linked to celiac disease risk on infant gut colonization by Bacteroides species.Interplay between human leukocyte antigen genes and the microbial colonization process of the newborn intestine.Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.Acetylcholine-producing T cells in the intestine regulate antimicrobial peptide expression and microbial diversity.Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.Pivotal Advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease.High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production.Increased prevalence of pathogenic bacteria in the gut microbiota of infants at risk of developing celiac disease: the PROFICEL study.Modulation of phenotypic and functional maturation of dendritic cells by intestinal bacteria and gliadin: relevance for celiac disease.Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAIDProton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosisComparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkersEditorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' replyInvestigation of the Gut Microbiome in Patients with Schizophrenia and Clozapine-Induced Weight Gain: Protocol and Clinical Characteristics of First Patient Cohorts
P50
Q27026098-A970B3CE-37B6-46ED-9775-21804028E5FBQ31122535-4720C3E9-CAD3-49FD-8E75-2C7DC18DA46DQ33534036-F1A7C79D-FDD5-4072-A9DB-829970BC2428Q33797774-EAEE3081-61DD-4FD4-80BC-54F9F94AD60BQ34031910-36871CB3-EF2D-4A4A-A395-F622D83C372EQ34129427-7C5AE3B2-402E-414E-8F55-117BB0554625Q34518185-FBC682C6-E70B-485A-A737-CF6A476A86B7Q35139300-3A1827D1-171C-4D93-8F2A-8FE7AF4C0B7FQ35155407-560D88C8-82ED-460E-BE77-DE37BD455B03Q35540435-FF29A529-7A07-4A57-A834-FF5E73F7E65CQ35720168-61DA395B-E772-4BA1-A8D5-5F642B2DC4C6Q35995768-61EE3976-48C3-470F-9772-6673B05E4EC4Q40030609-A72AA14D-1EA8-4BF6-B79D-1E58299E1977Q41759501-6F84BC27-4369-46EF-A363-E20D1E4C8F80Q42198341-27C5B0FC-0D26-4F1E-9B7E-A01B1A4D1F2EQ44455167-4D60743A-4C2E-448C-A1AD-F400D2A60741Q46410539-13BC5C94-E2C9-4736-8F75-EBE0B07150A1Q46465650-D217C825-07EC-4589-99B7-92C8C6CA6FAAQ47322440-ACF34449-06E1-464F-87B8-328598EF267EQ51642585-22C5DD45-6D1B-40A1-BE5E-28789DA3BC41Q51736503-3832F545-0CBE-4ABA-A10F-05EAAFAE818AQ52578126-7E139D63-803D-450B-8B38-6FAEB1B4457DQ54296760-047BC1D3-45E0-4681-A2C7-F55D1F8F5F5DQ57144376-C49EE415-FF46-4B10-A0C4-1AFB20DBEBC4Q84538462-F4B07218-6E11-4714-988E-BE22F57E839AQ91300877-92A547EC-53FB-4B55-BCEE-6D2FCF57B993Q92669042-A568E7FA-9865-41A2-B564-4D6370129481Q92720676-7B1F74E4-B656-4909-8E1A-81DC2F8FD594
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Giada De Palma
@en
Giada De Palma
@nl
type
label
Giada De Palma
@en
Giada De Palma
@nl
prefLabel
Giada De Palma
@en
Giada De Palma
@nl
P31
P496
0000-0002-2063-7741